NCT06073223Completed
Intervention to Decrease Overtreatment of Patients With Low-risk Thyroid Cancer
Pilot Study of an Intervention to Decrease Overtreatment of Patients With Low-risk Thyroid Cancer
Source: ClinicalTrials.gov · Last updated 17 Feb 2026
Brief summary (registry, in English)
The study will include 50 patients newly diagnosed with low-risk thyroid cancer ranging from 18-80 years of age. After scheduling their surgeon visit, the investigators will enroll patients and measure their intended treatment choice, baseline awareness of the three treatment options, expected outcomes, self-efficacy, and activation. The participants will then be randomized 1:1 and deliver the CQUPLE intervention to the intervention group. The control group will receive usual care, which involves providing no disease or treatment specific information outside the surgeon visit. The study team will repeat all measures prior to the surgical consult and after the surgical consult. The study team will record the patients' actual treatment choice after the consult.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 50 (actual)
- First submitted
- 26 Sept 2023
- Start date
- 18 Sept 2023
- Primary completion date
- 20 Dec 2025
- Lead sponsor
- University of Michigan Rogel Cancer Center
- Diseases
- Thyroid cancer
- NCT number
- NCT06073223
What you commit to
- Study type: Interventional
- Participants enrolled: 50
- From 18 Sept 2023 to the primary completion date, 20 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- History of previous thyroid cancer or thyroid surgery and parathyroid surgery
- Performs at least one thyroid surgery annually on adults
Other
- Non-English speaking
- Deaf
- Subject Selection (for Surgeons)
- Surgeon Inclusion Criteria
- Credentialed at Michigan Medicine
- Surgeon Exclusion Criteria
- None
Who the study is looking for
- Age 18 to 80 years
- Low risk papillary thyroid cancer or highly suspicious for cancer
- Low risk papillary thyroid cancer
- cT1-2: Tumor size 4 cm or smaller and limited to the thyroid on ultrasound
- cN0: No evidence of lymph node metastasis on ultrasound
- cM0: No evidence of distant metastasis on imaging
- Highly suspicious for cancer
- Cytology meeting Bethesda V or Bethesday III or IV with molecular testing indicating a 70% risk of greater of thyroid cancer
- Nodule size 4 cm and smaller
- Limited to the thyroid on ultrasound
- No evidence of suspicious lymph nodes
- No evidence of thyroid cancer outside of the neck
- Referred for surgical consultation.
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The University of Michigan Cancer Center Coordinator of this site? Confirm its status | Ann Arbor | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.